News Contact Us Careers Get E-Mail alerts Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

See below for our most recent and archived news events.

Click below for current and archived news related to the company.

ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

Mar 18, 2021 8:00am EDT

ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit

Mar 04, 2021 8:00am EST

ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

Mar 03, 2021 8:00am EST

ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting

Feb 26, 2021 8:00am EST

ADMA Biologics to Participate in Raymond James Institutional Investor Conference

Feb 22, 2021 8:00am EST

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN

Feb 01, 2021 8:00am EST

ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™

Jan 26, 2021 8:00am EST

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook

Jan 19, 2021 8:00am EST

ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™

Jan 04, 2021 8:00am EST

ADMA Biologics Adopts Limited Duration Stockholder Rights Plan

Dec 16, 2020 4:15pm EST

1
2
3
4
5
6
7
8
9
10
...23